Abstract
World Health Organization-classified very severe pneumonia due to Pneumocystis jirovecii infection is recognized as a life-threatening condition in human immunodefi ciency virus (HIV) infected infants. We recount the use of nasal bubble continuous positive airway pressure (BCPAP) in an HIV-infected African infant with very severe pneumonia and treatment failure due to suspected infection with P. jirovecii. We also examine the potential implications of BCPAP use in resource-poor settings with a high case index of acute respiratory failure due to HIV-related pneumonia, but limited access to mechanical ventilation.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 562-564 |
| Number of pages | 3 |
| Journal | International Journal of Tuberculosis and Lung Disease |
| Volume | 15 |
| Issue number | 4 |
| DOIs | |
| State | Published - Apr 2011 |
| Externally published | Yes |
Keywords
- BCPAP
- Early infant diagnosis
- HIV
- Pneumocystis jirovecii pneumonia
- Sub-Saharan Africa
ASJC Scopus subject areas
- Pulmonary and Respiratory Medicine
- Infectious Diseases
Fingerprint Dive into the research topics of 'Bubble continuous positive airway pressure in a human immunodeficiency virus-infected infant'. Together they form a unique fingerprint.
Cite this
McCollum, E. D., Smith, A., & Golitko, C. L. (2011). Bubble continuous positive airway pressure in a human immunodeficiency virus-infected infant. International Journal of Tuberculosis and Lung Disease, 15(4), 562-564. https://doi.org/10.5588/ijtld.10.0583